Robust control of burst suppression for medical coma

Objective. Medical coma is an anesthetic-induced state of brain inactivation, manifest in the electroencephalogram by burst suppression. Feedback control can be used to regulate burst suppression, however, previous designs have not been robust. Robust control design is critical under real-world oper...

Full description

Bibliographic Details
Main Authors: Kim, Seong-Eun, Ching, ShiNung, Brown, Emery N., Westover, M. Brandon, Purdon, Patrick L.
Other Authors: Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Format: Article
Language:en_US
Published: IOP Publishing 2016
Online Access:http://hdl.handle.net/1721.1/102355
https://orcid.org/0000-0003-2668-7819
https://orcid.org/0000-0002-4518-4208
_version_ 1811097689987743744
author Kim, Seong-Eun
Ching, ShiNung
Brown, Emery N.
Westover, M. Brandon
Purdon, Patrick L.
author2 Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
author_facet Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
Kim, Seong-Eun
Ching, ShiNung
Brown, Emery N.
Westover, M. Brandon
Purdon, Patrick L.
author_sort Kim, Seong-Eun
collection MIT
description Objective. Medical coma is an anesthetic-induced state of brain inactivation, manifest in the electroencephalogram by burst suppression. Feedback control can be used to regulate burst suppression, however, previous designs have not been robust. Robust control design is critical under real-world operating conditions, subject to substantial pharmacokinetic and pharmacodynamic parameter uncertainty and unpredictable external disturbances. We sought to develop a robust closed-loop anesthesia delivery (CLAD) system to control medical coma. Approach. We developed a robust CLAD system to control the burst suppression probability (BSP). We developed a novel BSP tracking algorithm based on realistic models of propofol pharmacokinetics and pharmacodynamics. We also developed a practical method for estimating patient-specific pharmacodynamics parameters. Finally, we synthesized a robust proportional integral controller. Using a factorial design spanning patient age, mass, height, and gender, we tested whether the system performed within clinically acceptable limits. Throughout all experiments we subjected the system to disturbances, simulating treatment of refractory status epilepticus in a real-world intensive care unit environment. Main results. In 5400 simulations, CLAD behavior remained within specifications. Transient behavior after a step in target BSP from 0.2 to 0.8 exhibited a rise time (the median (min, max)) of 1.4 [1.1, 1.9] min; settling time, 7.8 [4.2, 9.0] min; and percent overshoot of 9.6 [2.3, 10.8]%. Under steady state conditions the CLAD system exhibited a median error of 0.1 [−0.5, 0.9]%; inaccuracy of 1.8 [0.9, 3.4]%; oscillation index of 1.8 [0.9, 3.4]%; and maximum instantaneous propofol dose of 4.3 [2.1, 10.5] mg kg[superscript −1]. The maximum hourly propofol dose was 4.3 [2.1, 10.3] mg kg[superscript −1] h[superscript −1]. Performance fell within clinically acceptable limits for all measures. Significance. A CLAD system designed using robust control theory achieves clinically acceptable performance in the presence of realistic unmodeled disturbances and in spite of realistic model uncertainty, while maintaining infusion rates within acceptable safety limits.
first_indexed 2024-09-23T17:03:21Z
format Article
id mit-1721.1/102355
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T17:03:21Z
publishDate 2016
publisher IOP Publishing
record_format dspace
spelling mit-1721.1/1023552022-10-03T10:06:30Z Robust control of burst suppression for medical coma Kim, Seong-Eun Ching, ShiNung Brown, Emery N. Westover, M. Brandon Purdon, Patrick L. Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences Picower Institute for Learning and Memory Kim, Seong-Eun Brown, Emery N. Objective. Medical coma is an anesthetic-induced state of brain inactivation, manifest in the electroencephalogram by burst suppression. Feedback control can be used to regulate burst suppression, however, previous designs have not been robust. Robust control design is critical under real-world operating conditions, subject to substantial pharmacokinetic and pharmacodynamic parameter uncertainty and unpredictable external disturbances. We sought to develop a robust closed-loop anesthesia delivery (CLAD) system to control medical coma. Approach. We developed a robust CLAD system to control the burst suppression probability (BSP). We developed a novel BSP tracking algorithm based on realistic models of propofol pharmacokinetics and pharmacodynamics. We also developed a practical method for estimating patient-specific pharmacodynamics parameters. Finally, we synthesized a robust proportional integral controller. Using a factorial design spanning patient age, mass, height, and gender, we tested whether the system performed within clinically acceptable limits. Throughout all experiments we subjected the system to disturbances, simulating treatment of refractory status epilepticus in a real-world intensive care unit environment. Main results. In 5400 simulations, CLAD behavior remained within specifications. Transient behavior after a step in target BSP from 0.2 to 0.8 exhibited a rise time (the median (min, max)) of 1.4 [1.1, 1.9] min; settling time, 7.8 [4.2, 9.0] min; and percent overshoot of 9.6 [2.3, 10.8]%. Under steady state conditions the CLAD system exhibited a median error of 0.1 [−0.5, 0.9]%; inaccuracy of 1.8 [0.9, 3.4]%; oscillation index of 1.8 [0.9, 3.4]%; and maximum instantaneous propofol dose of 4.3 [2.1, 10.5] mg kg[superscript −1]. The maximum hourly propofol dose was 4.3 [2.1, 10.3] mg kg[superscript −1] h[superscript −1]. Performance fell within clinically acceptable limits for all measures. Significance. A CLAD system designed using robust control theory achieves clinically acceptable performance in the presence of realistic unmodeled disturbances and in spite of realistic model uncertainty, while maintaining infusion rates within acceptable safety limits. 2016-05-02T17:08:39Z 2016-05-02T17:08:39Z 2015-05 2015-03 Article http://purl.org/eprint/type/JournalArticle 1741-2560 1741-2552 http://hdl.handle.net/1721.1/102355 Westover, M Brandon, Seong-Eun Kim, ShiNung Ching, Patrick L Purdon, and Emery N Brown. “Robust Control of Burst Suppression for Medical Coma.” Journal of Neural Engineering 12, no. 4 (May 28, 2015): 046004. https://orcid.org/0000-0003-2668-7819 https://orcid.org/0000-0002-4518-4208 en_US http://dx.doi.org/10.1088/1741-2560/12/4/046004 Journal of Neural Engineering Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf IOP Publishing PMC
spellingShingle Kim, Seong-Eun
Ching, ShiNung
Brown, Emery N.
Westover, M. Brandon
Purdon, Patrick L.
Robust control of burst suppression for medical coma
title Robust control of burst suppression for medical coma
title_full Robust control of burst suppression for medical coma
title_fullStr Robust control of burst suppression for medical coma
title_full_unstemmed Robust control of burst suppression for medical coma
title_short Robust control of burst suppression for medical coma
title_sort robust control of burst suppression for medical coma
url http://hdl.handle.net/1721.1/102355
https://orcid.org/0000-0003-2668-7819
https://orcid.org/0000-0002-4518-4208
work_keys_str_mv AT kimseongeun robustcontrolofburstsuppressionformedicalcoma
AT chingshinung robustcontrolofburstsuppressionformedicalcoma
AT brownemeryn robustcontrolofburstsuppressionformedicalcoma
AT westovermbrandon robustcontrolofburstsuppressionformedicalcoma
AT purdonpatrickl robustcontrolofburstsuppressionformedicalcoma